Jan 16, 2020 - Let's see if Allergan (AGN) stock is a good choice for value-oriented investors right now from multiple angles.
Jan 16, 2020 - J&J (JNJ) seeks label expansion for its new nasal spray, Spravato (esketamine), for an expanded patient population in Europe.
Jan 15, 2020 - Despite all the positivity, investors should think about adding a few large-cap stocks that pay a solid dividend to help anchor their portfolios in 2020...
Jan 13, 2020 - Aclaris (ACRS) announces favorable preliminary data from the phase I study on its investigational candidate ATI-450, presently being developed for treating immuno-inflammatory diseases. Stock rises.
Jan 08, 2020 - The company is leaving the aesthetics unit largely intact.
Jan 06, 2020 - Editas (EDIT) progresses well on developing its lead candidate EDIT-101 to treat LCA10, a rare genetic illness that causes blindness. Excessive reliance on partners for revenues remains a concern.
Jan 03, 2020 - Geopolitcal headwinds sent stocks lower on Friday as US officials confirmed that President Trump's airstrike killed Iran's top military commander.
Jan 03, 2020 - European authorities accept Aerie's (AERI) filing for its second ophthalmology drug, Roclanda.
Dec 27, 2019 - The stock market continued its end of the year rally Friday as the three major indices all hit new intraday highs.
Dec 24, 2019 - Allergan (AGN) gets FDA nod for Ubrelvy for the acute treatment of migraine with or without aura in adults.